DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 117 filers reported holding DYNE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,030,039 | +656.3% | 338,174 | +849.6% | 0.00% | – |
| Q2 2023 | $400,635 | +29.7% | 35,612 | +32.5% | 0.00% | – |
| Q1 2023 | $309,000 | +130279.7% | 26,869 | +31.4% | 0.00% | – |
| Q4 2022 | $237 | -100.0% | 20,444 | -53.3% | 0.00% | – |
| Q3 2022 | $557,000 | +130.2% | 43,776 | +23.9% | 0.00% | – |
| Q2 2022 | $242,000 | -9.7% | 35,320 | +26.8% | 0.00% | – |
| Q1 2022 | $268,000 | -40.4% | 27,858 | -26.4% | 0.00% | – |
| Q4 2021 | $450,000 | -70.4% | 37,838 | -59.6% | 0.00% | – |
| Q3 2021 | $1,522,000 | +355.7% | 93,683 | +491.1% | 0.00% | – |
| Q2 2021 | $334,000 | +111.4% | 15,848 | +55.8% | 0.00% | – |
| Q1 2021 | $158,000 | +17.9% | 10,169 | +59.4% | 0.00% | – |
| Q4 2020 | $134,000 | – | 6,380 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $25,730,194 | 34.58% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $57,385,602 | 24.01% |
| Atlas Venture Life Science Advisors, LLC | 9,869,483 | $114,387,308 | 13.78% |
| Logos Global Management LP | 2,150,000 | $24,918,500 | 2.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 641,068 | $7,417,157 | 2.29% |
| Deep Track Capital, LP | 2,684,200 | $31,109,878 | 1.31% |
| EcoR1 Capital, LLC | 2,322,384 | $26,916,431 | 0.82% |
| Vivo Capital, LLC | 577,642 | $6,695 | 0.77% |
| HighVista Strategies LLC | 102,431 | $1,187,175 | 0.70% |
| Monashee Investment Management LLC | 123,719 | $1,433,903 | 0.62% |